HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,775,233 | -7.3% | 220,755 | -11.9% | 0.05% | -5.6% |
Q2 2023 | $21,332,253 | -8.6% | 250,555 | -11.1% | 0.05% | -10.0% |
Q1 2023 | $23,331,776 | -3.2% | 281,955 | -8.0% | 0.06% | -10.4% |
Q4 2022 | $24,102,686 | -6.0% | 306,455 | -11.5% | 0.07% | -9.5% |
Q3 2022 | $25,648,000 | -4.3% | 346,455 | -15.8% | 0.07% | -2.6% |
Q2 2022 | $26,812,000 | +2.1% | 411,355 | -1.0% | 0.08% | +8.6% |
Q1 2022 | $26,271,000 | +64.9% | 415,555 | +38.3% | 0.07% | +75.0% |
Q4 2021 | $15,936,000 | -23.9% | 300,455 | +1.3% | 0.04% | -25.9% |
Q3 2021 | $20,934,000 | +202.2% | 296,555 | +185.3% | 0.05% | +200.0% |
Q2 2021 | $6,928,000 | -63.0% | 103,955 | -38.3% | 0.02% | -64.7% |
Q1 2021 | $18,700,000 | -41.6% | 168,455 | -37.6% | 0.05% | -40.7% |
Q4 2020 | $32,033,000 | -27.5% | 269,755 | -46.7% | 0.09% | -31.7% |
Q3 2020 | $44,188,000 | +73.5% | 506,455 | +78.1% | 0.13% | +68.0% |
Q2 2020 | $25,467,000 | +35.5% | 284,355 | +50.8% | 0.08% | +4.2% |
Q1 2020 | $18,791,000 | -8.6% | 188,555 | +5.4% | 0.07% | +50.0% |
Q4 2019 | $20,562,000 | +16.8% | 178,955 | +28.2% | 0.05% | +11.6% |
Q3 2019 | $17,603,000 | -0.0% | 139,555 | -4.6% | 0.04% | -2.3% |
Q2 2019 | $17,606,000 | +15.3% | 146,300 | -16.2% | 0.04% | +12.8% |
Q1 2019 | $15,270,000 | -0.7% | 174,555 | +13.6% | 0.04% | -7.1% |
Q4 2018 | $15,378,000 | -17.1% | 153,700 | -5.1% | 0.04% | -6.7% |
Q3 2018 | $18,551,000 | +5.5% | 161,905 | -17.5% | 0.04% | -4.3% |
Q2 2018 | $17,592,000 | +56.0% | 196,160 | +27.3% | 0.05% | +51.6% |
Q1 2018 | $11,274,000 | -38.0% | 154,100 | -50.8% | 0.03% | -36.7% |
Q4 2017 | $18,197,000 | +331.4% | 313,305 | +233.3% | 0.05% | +308.3% |
Q3 2017 | $4,218,000 | +17.9% | 94,005 | +3.8% | 0.01% | 0.0% |
Q2 2017 | $3,578,000 | +7.0% | 90,600 | +10.0% | 0.01% | +9.1% |
Q1 2017 | $3,343,000 | +66.7% | 82,400 | +65.1% | 0.01% | +37.5% |
Q4 2016 | $2,006,000 | +287.3% | 49,900 | +248.8% | 0.01% | +300.0% |
Q3 2016 | $518,000 | +155.2% | 14,305 | +146.4% | 0.00% | +100.0% |
Q1 2016 | $203,000 | -95.4% | 5,805 | -95.3% | 0.00% | -97.1% |
Q2 2014 | $4,375,000 | +34.0% | 124,005 | +23.8% | 0.03% | +13.3% |
Q1 2014 | $3,266,000 | – | 100,205 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |